174657-48-8

Basic information

• Product Name: 2-(2,3-diphenyl-4H-pyrrolo[1,2-a]benzimidazol-4-yl)-N,N-diethylethanamine sulfate
• CAS NO: 174657-48-8
• Molecular Formula: C₂₈H₃₁N₃O₄S
• Molecular Weight: 505.6284
• Mol File: 174657-48-8.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 529.6°C at 760 mmHg
• Flash Point: 274.1°C
• Vapor Pressure: 2.66E-11mmHg at 25°C
• CAS DataBase Reference: 2-(2,3-diphenyl-4H-pyrrolo[1,2-a]benzimidazol-4-yl)-N,N-diethylethanamine sulfate(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(2,3-diphenyl-4H-pyrrolo[1,2-a]benzimidazol-4-yl)-N,N-diethylethanamine sulfate(174657-48-8)
• EPA Substance Registry System: 2-(2,3-diphenyl-4H-pyrrolo[1,2-a]benzimidazol-4-yl)-N,N-diethylethanamine sulfate(174657-48-8)

Safety Data

• Hazardous Substances Data: 174657-48-8(Hazardous Substances Data)

Usage

Description

2-(2,3-diphenyl-4H-pyrrolo[1,2-a]benzimidazol-4-yl)-N,N-diethylethanamine sulfate, also known as DPEAPB, is a chemical compound belonging to the class of benzimidazole derivatives. It is a potent and selective sigma-1 receptor agonist with potential applications in neuroscience research. DPEAPB has been studied for its potential neuroprotective and anti-amnesic effects, as well as its potential for treating neurological disorders such as Alzheimer's disease. Its unique structure and pharmacological profile make it an interesting compound for further research and potential therapeutic development in the future.

Uses

Used in Neuroscience Research:
2-(2,3-diphenyl-4H-pyrrolo[1,2-a]benzimidazol-4-yl)-N,N-diethylethanamine sulfate is used as a research tool for studying the role of sigma-1 receptors in the nervous system. Its potent and selective agonist activity allows researchers to investigate the mechanisms of action and potential therapeutic effects of sigma-1 receptor modulation.
Used in Neuroprotection and Anti-amnesic Applications:
2-(2,3-diphenyl-4H-pyrrolo[1,2-a]benzimidazol-4-yl)-N,N-diethylethanamine sulfate is used as a potential neuroprotective and anti-amnesic agent. Its ability to modulate sigma-1 receptors has been shown to provide neuroprotection and improve cognitive function in preclinical models, making it a promising candidate for the development of treatments for neurological disorders associated with memory impairment.
Used in Alzheimer's Disease Treatment:
2-(2,3-diphenyl-4H-pyrrolo[1,2-a]benzimidazol-4-yl)-N,N-diethylethanamine sulfate is used as a potential therapeutic agent for the treatment of Alzheimer's disease. Its neuroprotective and anti-amnesic properties suggest that it may help slow the progression of cognitive decline and improve the quality of life for patients with this neurodegenerative disorder.
Used in Drug Development:
2-(2,3-diphenyl-4H-pyrrolo[1,2-a]benzimidazol-4-yl)-N,N-diethylethanamine sulfate is used as a lead compound in the development of new drugs targeting sigma-1 receptors. Its unique structure and pharmacological profile provide a foundation for the design and synthesis of novel compounds with improved potency, selectivity, and pharmacokinetic properties for the treatment of neurological disorders.